Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Hagens Berman Alerts iRhythm Technologies (IRTC) Investors of Investigation of Possible Disclosure Violations

IRTC

PR Newswire

SAN FRANCISCO, March 27, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in iRhythm Technologies, Inc. (NASDAQ: IRTC) of the firm's investigation of possible violations of the Federal securities laws.  If you purchased or otherwise acquired iRhythm Technologies securities before March 27, 2019 and suffered losses contact Hagens Berman Sobol Shapiro LLP.  For more information about the investigation click

https://www.hbsslaw.com/cases/IRTC

Hagens Berman Sobol Shapiro LLP (PRNewsfoto/Hagens Berman Sobol Shapiro LLP)

or contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing

IRTC@hbsslaw.com.

Between March 13, 2019 and March 27, 2019, certain analysts began publicly questioning (a) the sustainability of third party reimbursements to the Company attributable to sales of its Zio XT Extended Holter patch device, (b) whether the Company's and management's statements about the total addressable market for iRhythm products may have been misleading, and (c) whether the Company and management may have used "cookie jar" style accounting in accruing for bad debt expense and contractual allowances.

During the period in which these reports were published, the price of iRhythm shares has significantly fallen.

"We're focused on investors' losses, the matters raised in the reports, and whether investors may have been," said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding iRhythm should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email IRTC@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 78 attorneys in 9 offices across the country.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes can be found at www.hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hagens-berman-alerts-irhythm-technologies-irtc-investors-of-investigation-of-possible-disclosure-violations-300819803.html

SOURCE Hagens Berman Sobol Shapiro LLP



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today